edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Associated equity: Herantis Pharma
Herantis Pharma is a Finland-based clinical-stage biotechnology company focused on developing disease-modifying therapies to stop or reverse the progression of neurodegenerative diseases.
Herantis Pharma — 5 videos in collection
Herantis Pharma is a clinical-stage biotechnology company based in Finland, focused on developing disease-modifying therapies for neurodegenerative diseases. Its lead candidate, HER-096, is being developed for Parkinson’s disease (PD) and has been designed to target the underlying biology of the condition, rather than just its symptoms.
We highlight four key reasons why Herantis may be considered a compelling investment opportunity.
For further details, please refer to our latest research on Herantis Pharma.
Get access to the very latest content matched to your personal investment style.